Cyprotex was a contract research organisation specialising in in-vitro and in-silico ADME-tox testing. It was a leading outsource provider of such services to the pharmaceutical industry. It also provided in-vitro toxicity testing to the cosmetics and agrochemical industries. The company operated laboratories in both the UK and the US.

The business was sold to a large German drug discovery and development company.

Fund Fund 3
Investment date September 2013
Deal type PIPE
Sector Life sciences
Exit date December 2016
Exit type Trade sale
Back to Realised investments
City and trees